VSCIX
Price
$114.80
Change
-$3.11 (-2.64%)
Updated
Feb 21 closing price
Net Assets
160.88B
VYSZX
Price
$5.86
Change
-$0.16 (-2.66%)
Updated
Feb 21 closing price
Net Assets
171.58M
Ad is loading...

VSCIX vs VYSZX

Header iconVSCIX vs VYSZX Comparison
Open Charts VSCIX vs VYSZXBanner chart's image
Vanguard Small Cap Index I
Price$114.80
Change-$3.11 (-2.64%)
VolumeN/A
Net Assets160.88B
Voya Small Company C
Price$5.86
Change-$0.16 (-2.66%)
VolumeN/A
Net Assets171.58M
VSCIX vs VYSZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VSCIX vs. VYSZX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and VYSZX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 161B vs. VYSZX (172M). VSCIX pays higher dividends than VYSZX: VSCIX (1.43) vs VYSZX (0.00). VSCIX was incepted earlier than VYSZX: VSCIX (28 years) vs VYSZX (27 years). VYSZX is a more actively managed with annual turnover of: 314.00 vs. VSCIX (12.00). VYSZX has a lower initial minimum investment than VSCIX: VYSZX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 11.25 vs. VYSZX (-9.25). VSCIX return over 5 years is better than : 44.48 vs. VYSZX (-31.42).
VSCIXVYSZXVSCIX / VYSZX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years27 years-
Gain YTD-0.3041.560-19%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets161B172M93,605%
Annual Yield % from dividends1.430.00-
Returns for 1 year11.25-9.25-122%
Returns for 3 years18.86-8.28-228%
Returns for 5 years44.48-31.42-142%
Returns for 10 years105.81-56.88-186%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FENC6.650.05
+0.76%
Fennec Pharmaceuticals
NERV1.82-0.02
-1.09%
Minerva Neurosciences
LDOS126.82-3.23
-2.48%
Leidos Holdings
APAM42.21-1.72
-3.92%
Artisan Partners Asset Management
IMNM9.52-0.59
-5.84%
Immunome